Editorial ArticleRecombinase Polymerase Amplification - The Breakthrough Isothermal Alternative to PCR
Editorial ArticleThis State-of-the-Art Technology is Driving Groundbreaking Research into Cancer, Mental Health and Alzheimer’s Disease
Editorial ArticleWorld Class NHS Facility Drives Research and Innovation in Next Generation Sequencing
Product NewsCambridge Epigenetix Licenses Fundamental DNA Methylation Intellectual Property from Boston Children’s Hospital
Product NewsUniversity Hospital Basel Institute of Pathology Established as Thermo Fisher Scientific Center of Excellence Partner
Product NewsHamilton Robotics Collaborates with Illumina to Develop a Non-Invasive Prenatal Testing Solution
Industry NewsNew cfDNA Purification Technologies Used for Fetal Sex Determination, Screening of Genetic Disorders and Cancer
Editorial ArticleNucleic Acid Metrology: The Value of Inter-laboratory Reproducibility in Digital PCR
Industry NewsAnalytik Jena Finds Entry into the Ultra-High Throughput Genotyping Market Through Co-Marketing Agreement with Illumina
Expert InsightsYour Questions Answered – Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with Castration-Resistant Prostate Cancer
Product NewsMammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC
Product NewsBioTek Celebrates Multiple SelectScience<sup>®</sup> Scientists’ Choice Awards<sup>®</sup>
Expert InsightsFree Webinar – Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with Castration-Resistant Prostate Cancer
